.jpg?format=webp&quality=80&width=3840)
A study examined the occurrence of death during percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) in the Prospective Global Registry for the Study of CTO Interventions (PROGRESS-CTO). Out of 12,928 patients who underwent the procedure between 2012 and 2022, 0.4% (52) died during their hospitalization. Patients who died were more likely to have a history of heart failure. Higher scores on the J-CTO, PROGRESS-CTO mortality, and PROGRESS-CTO pericardiocentesis scales were observed in patients who died. Cardiac causes accounted for 83% of deaths, with tamponade being the leading cause. The study suggests that complication scores can aid in risk assessment and planning for CTO-PCI procedures.
Like
Save
Share